Kalvista Begin Period Cash Flow from 2010 to 2024
| KALV Stock | USD 10.06 0.03 0.30% |
Begin Period Cash Flow | First Reported 2013-10-31 | Previous Quarter 23.1 M | Current Value 31.8 M | Quarterly Volatility 24.1 M |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Begin Period Cash Flow |
Latest Kalvista Pharmaceuticals' Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Kalvista Pharmaceuticals over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Kalvista Pharmaceuticals' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Kalvista Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 21,917,000 | |
| Geometric Mean | 14,144,923 | |
| Coefficient Of Variation | 86.49 | |
| Mean Deviation | 16,009,467 | |
| Median | 15,789,000 | |
| Standard Deviation | 18,956,381 | |
| Sample Variance | 359.3T | |
| Range | 52.3M | |
| R-Value | 0.60 | |
| Mean Square Error | 249.1T | |
| R-Squared | 0.36 | |
| Significance | 0.02 | |
| Slope | 2,530,100 | |
| Total Sum of Squares | 5030.8T |
Kalvista Begin Period Cash Flow History
About Kalvista Pharmaceuticals Financial Statements
Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 56.2 M | 3.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.